First things first. They are going to need lots of money to do the Phase 2, and thenPhase 3 studies. Hundreds of millions. So either debt or equity offering or some kind of collaboration with big pharma, which would be smart. This company, with no revenue and $8 M in cash cannot do it by itself.$Neurosense Therapeutics Ltd(NRSN)$
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
1
举报
登录后可参与评论

暂无评论